Cargando…
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects
Saving lives and flattening the curve are the foremost priorities during the ongoing pandemic spread of SARS-CoV-2. Developing cutting-edge technology and collating available evidence would support frontline health teams. Nutritional adequacy improves general health and immunity to prevent and assua...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972717/ https://www.ncbi.nlm.nih.gov/pubmed/33785208 http://dx.doi.org/10.1016/j.arcmed.2021.03.002 |
_version_ | 1783666716646047744 |
---|---|
author | Kurian, Shilia Jacob Unnikrishnan, Mazhuvancherry Kesavan Miraj, Sonal Sekhar Bagchi, Debasis Banerjee, Mithu Reddy, B. Shrikar Rodrigues, Gabriel Sunil Manu, Mohan K. Saravu, Kavitha Mukhopadhyay, Chiranjay Rao, Mahadev |
author_facet | Kurian, Shilia Jacob Unnikrishnan, Mazhuvancherry Kesavan Miraj, Sonal Sekhar Bagchi, Debasis Banerjee, Mithu Reddy, B. Shrikar Rodrigues, Gabriel Sunil Manu, Mohan K. Saravu, Kavitha Mukhopadhyay, Chiranjay Rao, Mahadev |
author_sort | Kurian, Shilia Jacob |
collection | PubMed |
description | Saving lives and flattening the curve are the foremost priorities during the ongoing pandemic spread of SARS-CoV-2. Developing cutting-edge technology and collating available evidence would support frontline health teams. Nutritional adequacy improves general health and immunity to prevent and assuage infections. This review aims to outline the potential role of probiotics in fighting the COVID-19 by covering recent evidence on the association between microbiota, probiotics, and COVID-19, the role of probiotics as an immune-modulator and antiviral agent. The high basic reproduction number (R0) of SARS-CoV-2, absence of conclusive remedies, and the pleiotropic effect of probiotics in fighting influenza and other coronaviruses together favour probiotics supplements. However, further support from preclinical and clinical studies and reviews outlining the role of probiotics in COVID-19 are critical. Results are awaited from many ongoing clinical trials investigating the benefits of probiotics in COVID-19. |
format | Online Article Text |
id | pubmed-7972717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79727172021-03-19 Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects Kurian, Shilia Jacob Unnikrishnan, Mazhuvancherry Kesavan Miraj, Sonal Sekhar Bagchi, Debasis Banerjee, Mithu Reddy, B. Shrikar Rodrigues, Gabriel Sunil Manu, Mohan K. Saravu, Kavitha Mukhopadhyay, Chiranjay Rao, Mahadev Arch Med Res Review Article Saving lives and flattening the curve are the foremost priorities during the ongoing pandemic spread of SARS-CoV-2. Developing cutting-edge technology and collating available evidence would support frontline health teams. Nutritional adequacy improves general health and immunity to prevent and assuage infections. This review aims to outline the potential role of probiotics in fighting the COVID-19 by covering recent evidence on the association between microbiota, probiotics, and COVID-19, the role of probiotics as an immune-modulator and antiviral agent. The high basic reproduction number (R0) of SARS-CoV-2, absence of conclusive remedies, and the pleiotropic effect of probiotics in fighting influenza and other coronaviruses together favour probiotics supplements. However, further support from preclinical and clinical studies and reviews outlining the role of probiotics in COVID-19 are critical. Results are awaited from many ongoing clinical trials investigating the benefits of probiotics in COVID-19. Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. 2021-08 2021-03-19 /pmc/articles/PMC7972717/ /pubmed/33785208 http://dx.doi.org/10.1016/j.arcmed.2021.03.002 Text en © 2021 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Kurian, Shilia Jacob Unnikrishnan, Mazhuvancherry Kesavan Miraj, Sonal Sekhar Bagchi, Debasis Banerjee, Mithu Reddy, B. Shrikar Rodrigues, Gabriel Sunil Manu, Mohan K. Saravu, Kavitha Mukhopadhyay, Chiranjay Rao, Mahadev Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects |
title | Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects |
title_full | Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects |
title_fullStr | Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects |
title_full_unstemmed | Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects |
title_short | Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects |
title_sort | probiotics in prevention and treatment of covid-19: current perspective and future prospects |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972717/ https://www.ncbi.nlm.nih.gov/pubmed/33785208 http://dx.doi.org/10.1016/j.arcmed.2021.03.002 |
work_keys_str_mv | AT kurianshiliajacob probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT unnikrishnanmazhuvancherrykesavan probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT mirajsonalsekhar probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT bagchidebasis probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT banerjeemithu probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT reddybshrikar probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT rodriguesgabrielsunil probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT manumohank probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT saravukavitha probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT mukhopadhyaychiranjay probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects AT raomahadev probioticsinpreventionandtreatmentofcovid19currentperspectiveandfutureprospects |